Ab Therapeutics

The Barcelona Based Biotech Company is in a Series-A Fundraising Round to Conduct Preclinical Development and to File an IND in Late 2011

Older News

BARCELONA, November 10, 2010 - The Barcelona-based biotech company AB Therapeutics has obtained high efficacy results with its 2 new anticancer compounds in animal models of lung cancer (NSCLC) using Membrane Lipid Therapy (MLT), a new therapeutic approach.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy